Multiple Sclerosis Clinical Trial
— REEN-SEPOfficial title:
Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients
Verified date | October 2023 |
Source | Centre Hospitalier Universitaire de Saint Etienne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.
Status | Terminated |
Enrollment | 30 |
Est. completion date | June 30, 2022 |
Est. primary completion date | February 23, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Aged 18 to 70 years old - Male or female - With relapsing-remitting multiple sclerosis (RRMS) as defined by McDonald's 2010 criteria. - Between 2 and 25 years from the onset of multiple sclerosis - With a high level of fatigue, corresponding to a score of Fatigue Severity Scale> 4 and Fatigue questionnaire > 38. - Expanded Disability Status Scale Score 5 - Testing = 4 in all leg muscles. - Ability to walk for 10 minutes without stopping (self-reported) - Affiliates or beneficiaries of a social security scheme - Having freely given their written consent after having been informed of the purpose, course of action and potential risks involved Exclusion Criteria: - Severe cerebellar spasticity or ataxia in either leg. - Abnormal range of motion of the toes and/or ankle. - Musculoskeletal injury that interferes with pedaling. - High resting heart rate (>90 beats per minute). - Blood pressure > 144/94 mmHg. - Onset of a multiple sclerosis attack within 90 days prior to the study. - Recent adjustment of any medication or drugs that may impact on fatigue, or taking stimulants for fatigue (e.g. Modafinil). - Taking of neuro-active substances that may impair cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) throughout the study period. - Contraindication to the application of a magnetic field - History of co-morbid disease or conditions that would compromise the subject's safety during the study. - Participation at the same time in another medical intervention study or having participated in such a study within 30 days prior to this study. - Pregnant and Nursing Women - Women of childbearing age without effective contraception - Patient unable to understand the purpose and conditions of the study, incapable of giving consent - Patient deprived of liberty or patient under guardianship |
Country | Name | City | State |
---|---|---|---|
France | CHU de Saint-Etienne | Saint-Étienne |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Saint Etienne |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Chronic fatigue score | assessed using the Fatigue Severity Scale (FSS) questionnaire before and after an individualized re-training program compared to a traditional re-training program in MS patients. | Month 3 | |
Secondary | cardiorespiratory fitness | evaluated by measuring the maximum oxygen consumption (VO2max) during an incremental exercise on a cycloergometer. | Month 3 | |
Secondary | Hematological parameters | red blood cell and hemoglobin levels measured by spectrophotometry. | Month 3 | |
Secondary | Inflammatory parameters | c-reactive protein | Month 3 | |
Secondary | quality of sleep | actigraphy measurements and sleep diary records | Month 3 | |
Secondary | cortical activation level | transcranial magnetic stimulation | Month 3 | |
Secondary | cortico-spinal excitability | transcranial magnetic stimulation | Month 3 | |
Secondary | neuromuscular fatigue of peripheral function | electrical nerve stimulation | Month 3 | |
Secondary | Analysis overall quality of life : Fatigue questionnaire | Fatigue questionnaire by Modified Fatigue Impact Scale (MFIS) results | Month 3 | |
Secondary | Analysis overall quality of life :Quality of Life | Quality of Life Questionnaire by SEP-59 results | Month 3 | |
Secondary | Analysis overall quality of life :Depression | Depression Questionnaire by Center for Epidemiologic Studies Depression (CES-D) results | Month 3 | |
Secondary | Analysis overall quality of life : Sleep Quality | Sleep Quality Questionnaire by Pittsburgh Sleep Quality Index (PSQ-I) results | Month 3 | |
Secondary | Analysis overall quality of life : Physical Activity | Physical Activity Questionnaire by Godin Leisure-Time Exercise Questionnaire (GLTEQ) results | Month 3 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |